This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limiteds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Get Detail Report With TOC @ http://www.researchmoz.us/glycomar-limited-product-pipeline-review-2014-report.html The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

1. GlycoMar Limited - Product Pipeline Review - 2014
GlycoMar Limited - Product Pipeline Review - 2014
Summary
Global Markets Directs, GlycoMar Limited - Product Pipeline Review - 2014, provides an overview of the GlycoMar Limiteds pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of GlycoMar Limiteds, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest
updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides brief overview of GlycoMar Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of GlycoMar Limiteds human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major
milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the GlycoMar Limiteds pipeline products
Reasons to buy
- Evaluate GlycoMar Limiteds strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of GlycoMar Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the GlycoMar Limiteds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of GlycoMar Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of GlycoMar Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Explore the dormant and discontinued projects of GlycoMar Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
glycomar Limited Snapshot 5
glycomar Limited Overview 5
key Information 5
key Facts 5
glycomar Limited - Research And Development Overview 6
key Therapeutic Areas 6
glycomar Limited - Pipeline Review 9
pipeline Products By Stage Of Development 9
pipeline Products - Monotherapy 10
pipeline Products - Partnered Products 11
partnered Products/combination Treatment Modalities 12
GlycoMar Limited - Product Pipeline Review - 2014

2. glycomar Limited - Pipeline Products Glance 13
glycomar Limited - Early Stage Pipeline Products 13
preclinical Products/combination Treatment Modalities 13
discovery Products/combination Treatment Modalities 14
glycomar Limited - Drug Profiles 15
gly-145 15
product Description 15
mechanism Of Action 15
r&d Progress 15
gly-2028 16
product Description 16
mechanism Of Action 16
r&d Progress 16
gly-079 17
product Description 17
mechanism Of Action 17
r&d Progress 17
gly-198 18
product Description 18
mechanism Of Action 18
r&d Progress 18
glyk-5006 19
product Description 19
mechanism Of Action 19
r&d Progress 19
inflammatory Bowel Disease Program 20
product Description 20
mechanism Of Action 20
r&d Progress 20
glycomar Limited - Pipeline Analysis 21
glycomar Limited - Pipeline Products By Target 21
glycomar Limited - Pipeline Products By Route Of Administration 22
glycomar Limited - Pipeline Products By Molecule Type 23
glycomar Limited - Pipeline Products By Mechanism Of Action 24
glycomar Limited - Locations And Subsidiaries 25
head Office 25
appendix 26
methodology 26
coverage 26
secondary Research 26
primary Research 26
expert Panel Validation 26
contact Us 27
disclaimer 27
list Of Tables
glycomar Limited, Key Information 5
glycomar Limited, Key Facts 5
glycomar Limited - Pipeline By Indication, 2014 8
glycomar Limited - Pipeline By Stage Of Development, 2014 9
glycomar Limited - Monotherapy Products In Pipeline, 2014 10
glycomar Limited - Partnered Products In Pipeline, 2014 11
glycomar Limited - Partnered Products/ Combination Treatment Modalities, 2014 12
glycomar Limited - Preclinical, 2014 13
glycomar Limited - Discovery, 2014 14
glycomar Limited - Pipeline By Target, 2014 21
glycomar Limited - Pipeline By Route Of Administration, 2014 22
glycomar Limited - Pipeline By Molecule Type, 2014 23
glycomar Limited - Pipeline Products By Mechanism Of Action, 2014 24
list Of Figures
glycomar Limited - Pipeline By Top 10 Indication, 2014 7
glycomar Limited - Pipeline By Stage Of Development, 2014 9
glycomar Limited - Monotherapy Products In Pipeline, 2014 10
glycomar Limited - Pipeline By Top 10 Route Of Administration, 2014 22
glycomar Limited - Pipeline By Top 10 Molecule Type, 2014 23
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
GlycoMar Limited - Product Pipeline Review - 2014

3. research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
GlycoMar Limited - Product Pipeline Review - 2014